Rock Springs Capital Management LP 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:50 pm Unchanged | 2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Rock Springs Capital Management LP | 3,003,259 6.830% | 0 (Unchanged) | Filing |
| 2024-04-05 2:51 pm Purchase | 2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO | Rock Springs Capital Management LP | 3,003,259 8.710% | 3,003,259 (New Position) | Filing |